Royal Infirmary of Edinburgh
Edinburgh, EH164SA, United Kingdom
Location status: Recruiting
Location contact
Neeraj Dhaun, MBChB PhD
CONTACT
NCT Number: NCT04522765
In health, blood pressure (BP) falls at night by >10% compared with day-time values. This natural dipping pattern is important as without it there is an increased risk of cardiovascular disease (CVD). Recent evidence suggests that chronotherapy (taking anti-hypertensive medication at bedtime instead of in the morning) may enhance nocturnal BP dipping and reduce the risk of CVD events. There is therefore an urgent need to characterise diurnal BP patterns in patients who may be at risk of reduced nocturnal dipping in order to maximise protective therapy in all those who would benefit. Similarly, it has previously been demonstrated that increased arterial stiffness is associated with increased CVD risk, however little is known about whether loss of diurnal variations in arterial stiffness confer addition risk. Kidney disease is independently associated with increased CVD events, but the exact makeup of this risk is not clear. Within this heterogenous cohort several very distinct groups exist including those with acute kidney injury (AKI), chronic kidney disease (CKD), inflammatory conditions like small vessel vasculitis (SVV), and those who have either donated or received a kidney transplant. Diurnal BP and arterial stiffness patterns within these patient groups are not well characterised. The investigators will recruit patients at increased risk of CVD from the Royal Infirmary of Edinburgh Renal and Vasculitis Clinics. Participants will undergo 24-hour ambulatory BP and arterial stiffness measurement in conjunction with day- and night-time blood and urine sampling on two separate occasions. This study aims to characterise diurnal patterns of BP and arterial stiffness in patients at increased risk of CVD and compare findings with healthy controls. In doing so, the investigators aim to allow more targeted CVD risk reduction strategies and improve long-term patient outcomes.
Interested in participating?
Request Info18 year–90 year
All sexes
Observational
Edinburgh, EH164SA, United Kingdom
Location status: Recruiting
Neeraj Dhaun, MBChB PhD
CONTACT
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Assessment of 24 hour blood pressure and arterial stiffness using Mobil-o-graph device
Time frame: 24 hours
Percentage change between mean day-time and mean night-time blood pressure
Time frame: 24 hours
Percentage change between mean day-time and mean night-time arterial stiffness
Time frame: Morning (06:00-12:00) and evening (18:00-00:00)
Measurement of urine ET-1 concentration in the morning (06:00 - 12:00) and in the evening (18:00-00:00)
Time frame: Morning (06:00-12:00) and evening (18:00-00:00)
Measurement of plasma ET-1 concentration in the morning (06:00 - 12:00) and in the evening (18:00-00:00)
Contact information is provided by the study sponsor or research team.
University of Edinburgh
Other
Diurnal Blood Pressure and Arterial Stiffness Patterns in Those at Increased Risk of Cardiovascular Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03325426
Behavior, Cardiovascular Diseases
San Francisco, California, United States
View Trial DetailsNCT05022498
Arterial Stiffness, Blood Pressure
Loughborough, United Kingdom
View Trial DetailsNCT04556422
Arterial Stiffness, Blood Pressure
Jyväskylä, Central Finland, Finland
View Trial DetailsNCT03135002
Cardiovascular Diseases, Cardiovascular Risk Factor
Leicester, Leicestershire, United Kingdom
View Trial Details